Swiss National Bank Arcturus Therapeutics Holdings Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Swiss National Bank holds 47,700 shares of ARCT stock, worth $838,565. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,700

Previous 47,700 -0.0%

Holding current value

$838,565

Previous $1.16 Million 4.65%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$24.35 - $44.39 $12,175 - $22,195	500 Added 1.06%	47,700 $1.16 Million
Q4 2023 Feb 06, 2024	SELL	$17.71 - $32.97 $95,634 - $178,038	-5,400 Reduced 10.27%	47,200 $1.49 Million
Q3 2023 Nov 08, 2023	BUY	$25.44 - $37.35 $12,720 - $18,675	500 Added 0.96%	52,600 $1.34 Million
Q2 2023 Aug 09, 2023	BUY	$23.94 - $32.36 $16,758 - $22,652	700 Added 1.36%	52,100 $1.49 Million
Q1 2023 May 10, 2023	SELL	$14.72 - $23.97 $92,736 - $151,011	-6,300 Reduced 10.92%	51,400 $1.23 Million
Q4 2022 Feb 08, 2023	BUY	$14.14 - $23.06 $25,452 - $41,508	1,800 Added 3.22%	57,700 $978,000
Q2 2022 Aug 09, 2022	BUY	$12.26 - $31.17 $73,560 - $187,020	6,000 Added 12.02%	55,900 $880,000
Q1 2022 May 09, 2022	BUY	$17.64 - $39.57 $63,504 - $142,452	3,600 Added 7.78%	49,900 $1.35 Million
Q2 2021 Aug 06, 2021	BUY	$25.79 - $42.11 $38,685 - $63,165	1,500 Added 3.35%	46,300 $1.57 Million
Q1 2021 May 07, 2021	BUY	$38.75 - $86.92 $27,125 - $60,844	700 Added 1.59%	44,800 $1.85 Million
Q4 2020 Feb 05, 2021	BUY	$34.61 - $123.66 $27,688 - $98,928	800 Added 1.85%	44,100 $1.91 Million
Q3 2020 Nov 09, 2020	BUY	$37.49 - $63.19 $374,900 - $631,900	10,000 Added 30.03%	43,300 $1.86 Million
Q2 2020 Aug 05, 2020	BUY	$12.66 - $58.27 $421,578 - $1.94 Million	33,300 New	33,300 $1.56 Million

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $467M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Arcturus Therapeutics Holdings Inc. Transaction History